William Radvak
Chief Executive Officer en MONITOR VENTURES INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Mr. William J.
Radvak is an Executive Chairman at NervGen Pharma Corp.
and a President, Chief Executive Officer & Director at Monitor Ventures, Inc. He is on the Board of Directors at Monitor Ventures, Inc. Mr. Radvak was previously employed as an Independent Director by Harrys Manufacturing, Inc., a Chairman & Chief Executive Officer by Silvio Ventures, Inc., a President, Chief Executive Officer & Director by Regency Gold Corp., and a President & Chief Executive Officer by Response Biomedical Corp.
He received his undergraduate degree from the University of British Columbia.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
NERVGEN PHARMA CORP.
2.37% | 28/03/2024 | 1 407 500 ( 2.37% ) | 2 M $ | 31/03/2024 |
Cargos activos de William Radvak
Empresas | Cargo | Inicio |
---|---|---|
MONITOR VENTURES INC. | Chief Executive Officer | 22/01/2010 |
NERVGEN PHARMA CORP. | Founder | 19/01/2017 |
Antiguos cargos conocidos de William Radvak.
Empresas | Cargo | Fin |
---|---|---|
CLEAN AIR METALS INC. | Chief Executive Officer | 29/04/2019 |
HARRYS MANUFACTURING INC. | Director/Board Member | 08/02/2019 |
Silvio Ventures, Inc. | Chairman | 18/07/2008 |
RESPONSE BIOMEDICAL CORP | Chief Executive Officer | - |
Formación de William Radvak.
University of British Columbia | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
MONITOR VENTURES INC. | Non-Energy Minerals |
CLEAN AIR METALS INC. | Non-Energy Minerals |
HARRYS MANUFACTURING INC. | Consumer Non-Durables |
NERVGEN PHARMA CORP. | Health Technology |
Empresas privadas | 2 |
---|---|
Response Biomedical Corp.
Response Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Response Biomedical Corp. engages in the research, development, commercialization, and distribution of diagnostic technologies. The firm serves the medical central-lab testing, point of care testing, and on-site environmental testing markets. It provides RAMP system, which is a portable fluorescence immunoassay-based diagnostic technology that combines the performance of a clinical lab with the convenience of a dipstick test. The company was founded on August 20, 1980 and is headquartered in Vancouver, Canada. | Commercial Services |
Silvio Ventures, Inc. | Finance |
- Bolsa de valores
- Insiders
- William Radvak